Marvin T. Nieman

3.9k total citations · 1 hit paper
71 papers, 2.7k citations indexed

About

Marvin T. Nieman is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Marvin T. Nieman has authored 71 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Hematology, 26 papers in Molecular Biology and 20 papers in Genetics. Recurrent topics in Marvin T. Nieman's work include Blood Coagulation and Thrombosis Mechanisms (33 papers), Platelet Disorders and Treatments (23 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (19 papers). Marvin T. Nieman is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (33 papers), Platelet Disorders and Treatments (23 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (19 papers). Marvin T. Nieman collaborates with scholars based in United States, United Kingdom and Germany. Marvin T. Nieman's co-authors include Margaret J. Wheelock, Keith R. Johnson, Alvin H. Schmaier, A R Redfield, Karen A. Knudsen, Han Xu, Amal Arachiche, María de la Fuente, Michele M. Mumaw and Anirban Sen Gupta and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Marvin T. Nieman

68 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

N-Cadherin Promotes Motility in Human Breast Cancer Cells Regardless of Their E-Cadherin Expression

1999 655 citations Marvin T. Nieman et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marvin T. Nieman United States	26	1.4k	759	472	349	333	71	2.7k
Takashi Murate Japan	32	2.0k 1.4×	944 1.2×	527 1.1×	221 0.6×	504 1.5×	137	3.5k
Tsukasa Ohmori Japan	26	1.7k 1.2×	774 1.0×	361 0.8×	280 0.8×	179 0.5×	108	3.2k
Marijke Bryckaert France	31	1.1k 0.7×	1.1k 1.4×	150 0.3×	387 1.1×	291 0.9×	69	2.6k
Bo Shen United States	21	1.4k 1.0×	480 0.6×	459 1.0×	192 0.6×	174 0.5×	35	2.8k
Giovanna Balconi Italy	22	1.5k 1.0×	423 0.6×	216 0.5×	275 0.8×	291 0.9×	47	2.8k
Wadie F. Bahou United States	36	1.5k 1.1×	1.5k 2.0×	686 1.5×	637 1.8×	529 1.6×	95	4.3k
Denise E. Jackson Australia	29	705 0.5×	1.1k 1.4×	258 0.5×	351 1.0×	165 0.5×	80	2.6k
Aaron J. Donner United States	15	1.1k 0.8×	655 0.9×	354 0.8×	129 0.4×	250 0.8×	18	2.1k
Irina Pleines Germany	21	654 0.5×	1.2k 1.6×	164 0.3×	455 1.3×	287 0.9×	31	2.5k
Valeria Ossovskaya United States	18	1.1k 0.8×	663 0.9×	916 1.9×	112 0.3×	395 1.2×	31	2.4k

Countries citing papers authored by Marvin T. Nieman

Since Specialization

Citations

This map shows the geographic impact of Marvin T. Nieman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marvin T. Nieman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marvin T. Nieman more than expected).

Fields of papers citing papers by Marvin T. Nieman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marvin T. Nieman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marvin T. Nieman. The network helps show where Marvin T. Nieman may publish in the future.

Co-authorship network of co-authors of Marvin T. Nieman

This figure shows the co-authorship network connecting the top 25 collaborators of Marvin T. Nieman. A scholar is included among the top collaborators of Marvin T. Nieman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marvin T. Nieman. Marvin T. Nieman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Huang, Guoying, et al.. (2025). From theory to platelets: unraveling the history and complexities of biased signaling. PubMed. 2(3). 100073–100073.

Huang, Guoying, et al.. (2025). Mice with reduced protease-activated receptor 4 reactivity show decreased venous thrombosis and platelet procoagulant activity. Journal of Thrombosis and Haemostasis. 23(4). 1278–1288. 2 indexed citations

Xu, Han, et al.. (2025). Elucidating the dynamics of integrin αIIbβ3 from native platelet membranes by cryo-EM with build-and-retrieve method. Blood Advances. 9(18). 4592–4606.

Xu, Han, Wei Li, Ronald A. Conlon, et al.. (2024). A mouse model of the protease-activated receptor 4 Pro310Leu variant has reduced platelet reactivity. Journal of Thrombosis and Haemostasis. 22(6). 1715–1726. 5 indexed citations

Xu, Han, Sepalika Bandara, Meng Cui, et al.. (2024). The Plasmodium falciparum NCR1 transporter is an antimalarial target that exports cholesterol from the parasite’s plasma membrane. Science Advances. 10(51). eadq6651–eadq6651. 1 indexed citations

Denorme, Frederik, Nicole D. Armstrong, Marshall L. Stoller, et al.. (2023). OC 03.4 A Common, Racially Diverse Protease Activated Receptor 4 Functional Variant Impacts Ischemic Stroke Outcomes: Evidence for a Pharmacogenetic Effect. Research and Practice in Thrombosis and Haemostasis. 7. 100312–100312. 1 indexed citations

Xu, Han, Pinunta Nittayacharn, Marvin T. Nieman, et al.. (2022). 99mTc /SPIO-loaded polymeric micelles as MRI and SPECT imaging, cancer-targeted nanoprobe for liver cancer detection. Journal of Drug Delivery Science and Technology. 79. 104060–104060. 4 indexed citations

Michael, James V., Xianguo Kong, Lin Ma, et al.. (2022). Human and mouse PAR4 are functionally distinct receptors: Studies in novel humanized mice. Journal of Thrombosis and Haemostasis. 20(5). 1236–1247. 7 indexed citations

Sekhon, Ujjal Didar Singh, Kelsey L. Swingle, Jurgis Alvikas, et al.. (2022). Platelet-mimicking procoagulant nanoparticles augment hemostasis in animal models of bleeding. Science Translational Medicine. 14(629). eabb8975–eabb8975. 51 indexed citations

10.

Mwirigi, Juliet M., Shayne Hassler, Ayesha Ahmad, et al.. (2021). A Role for Protease Activated Receptor Type 3 (PAR3) in Nociception Demonstrated Through Development of a Novel Peptide Agonist. Journal of Pain. 22(6). 692–706. 9 indexed citations

11.

Basak, Indranil, Frederik Denorme, Jesse W. Rowley, et al.. (2021). Neutrophil cathepsin G proteolysis of protease-activated receptor 4 generates a novel, functional tethered ligand. Blood Advances. 6(7). 2303–2308. 13 indexed citations

12.

Izem, Lahoucine, Katarzyna Białkowska, Elżbieta Pluskota, et al.. (2021). Plasminogen‐induced foam cell formation by macrophages occurs through a histone 2B (H2B)‐PAR1 pathway and requires integrity of clathrin‐coated pits. Journal of Thrombosis and Haemostasis. 19(4). 941–953. 5 indexed citations

13.

Xu, Han, et al.. (2020). PAR4 activation involves extracellular loop 3 and transmembrane residue Thr153. Blood. 136(19). 2217–2228. 21 indexed citations

14.

Gupta, Shuchi, Christoph Konradt, Adam Corken, et al.. (2020). Hemostasis vs. homeostasis: Platelets are essential for preserving vascular barrier function in the absence of injury or inflammation. Proceedings of the National Academy of Sciences. 117(39). 24316–24325. 39 indexed citations

15.

Fuente, María de la, et al.. (2020). Murine cadherin‐6 mediates thrombosis in vivo in a platelet‐independent manner. Research and Practice in Thrombosis and Haemostasis. 5(1). 125–131. 4 indexed citations

16.

Xu, Han, et al.. (2020). Expression and Purification of Protease-Activated Receptor 4 (PAR4) and Analysis with Histidine Hydrogen–Deuterium Exchange. Biochemistry. 59(5). 671–681. 7 indexed citations

17.

Cushman, Mary, Geoffrey D. Barnes, Mark A. Creager, et al.. (2020). Venous thromboembolism research priorities: A scientific statement from the American Heart Association and the International Society on Thrombosis and Haemostasis. Research and Practice in Thrombosis and Haemostasis. 4(5). 714–721. 9 indexed citations

18.

Xu, Han, María de la Fuente, & Marvin T. Nieman. (2020). Complement factor C4a does not activate protease‐activated receptor 1 (PAR1) or PAR4 on human platelets. Research and Practice in Thrombosis and Haemostasis. 5(1). 104–110. 7 indexed citations

19.

Nieman, Marvin T.. (2016). Protease-activated receptors in hemostasis. Blood. 128(2). 169–177. 107 indexed citations

20.

Zhai, Yali, Rong Wu, Donald R. Schwartz, et al.. (2002). Role of β-Catenin/T-Cell Factor-Regulated Genes in Ovarian Endometrioid Adenocarcinomas. American Journal Of Pathology. 160(4). 1229–1238. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact